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The objectives of this longitudinal study were to examine differences betweenwhites and blacks, and across two
geographical regions, in the socio-demographic, clinical, and psychosocial characteristics, hospital treatment
practices, and post-discharge mortality for hospital survivors of an acute coronary syndrome (ACS). In this pro-
spective cohort study, we performed in-person interviews and medical record abstractions for patients
discharged from the hospital after an ACS at participating sites in Central Massachusetts and Central Georgia dur-
ing 2011–2013. Among the 1143 whites in Central Massachusetts, 514 whites in Central Georgia, and 277 blacks
in Central Georgia, we observed a gradient of socioeconomic positionwithwhites in CentralMassachusetts being
themost privileged, followed bywhites and then blacks fromCentral Georgia; similar gradients pertained to psy-
chosocial vulnerability (e.g., 10.7%, 25.1%, and 49.1% had cognitive impairment, respectively) and to the hospital
receipt of all 4 evidence-based cardiacmedications (35.5%, 18.1%, and 14.4%, respectively) used in the acuteman-
agement of patients hospitalized with an ACS. Multivariable adjusted odds ratios (95% conﬁdence intervals) for
the receipt of a percutaneous coronary intervention for whites and blacks in Georgia vs. whites inMassachusetts
were 0.57 (0.46–0.71) and 0.40(0.30–0.52), respectively. Thirty-day and one-year mortality risks exhibited a
similar gradient.
The results of this contemporary clinical/epidemiologic study in a diverse patient cohort suggest that racial and
geographic disparities continue to exist for patients hospitalized with an ACS.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords:
Acute coronary syndromes
Race and geographic differences
Longitudinal study
1. Introduction
Racial differences in the treatment and outcomes of patients with
cardiovascular disease have long been acknowledged (Peterson et al.,
1997; Kiefe et al., 1997). These disparities have drawn signiﬁcant na-
tional attention and many calls for intervention to address them have
been issued by inﬂuential organizations (Yancy et al., 2011; American
Heart Association Report, n.d.; Institute of Medicine Report: Unequal
Treatment: Understanding Racial and Ethnic Disparities in Health, n.d.;
Healthy People 2020 Disparities Report, n.d.). Regional variability in
healthcare delivery is widely understood to occur and has sometimes
been interpreted as a marker of variability in the quality of care leading
to regional health disparities (Yeh et al., 2012; Gebreab and Diez Roux,
2012; Kulshreshtha et al., 2014; Gillum et al., 2012; Casper et al.,
2016; Spertus et al., 2009). Interpreting regional variability as indicative
of variable health care quality is particularly warrantedwhen variability
is observed in the delivery of evidence-based, guideline-recommended,
practices, as is the case for patients who develop an acute coronary syn-
drome. Whether and how potential regional disparities in healthcare
delivery and psychosocial/sociocultural factors are related to racial dis-
parities in health status and outcomes is less well understood.
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A limited number of observational studies in different regional set-
tings have examined differences in the characteristics, treatment prac-
tices, and prognosis between African Americans (blacks) and
European Americans (whites) who are discharged from the hospital
after an acute coronary event (Spertus et al., 2009; Mathews et al.,
2014; Sonel et al., 2005; Sabatine et al., 2005; Mehta et al., 2006; Ding
et al., 2003; Vaccarino et al., 2005); even fewer of these studies have
had access to detailed psychometric data.
Using data from the TRACE-CORE (Transitions, Risks, and Actions in
Coronary Events Center for Outcomes Research and Education) study
(Waring et al., 2012; Goldberg et al., 2015; McManus et al., 2016;
Cook et al., 2013), we examined differences in the socio-demographic,
clinical, and psychosocial characteristics, hospital treatment practices,
and 30 day and 1 year death risks betweenwhite and black patients liv-
ing in CentralMassachusetts and Central Georgia following hospital dis-
charge for an acute coronary syndrome (ACS).
2. Methods
Details of the study design, patient recruitment practices, and data
collection activities used in this longitudinal study have been described
previously (Waring et al., 2012; Goldberg et al., 2015; McManus et al.,
2016; Cook et al., 2013).
In brief, TRACE-CORE used a multi-site prospective cohort design to
recruit and follow a cohort of socioeconomically diverse adult men and
women hospitalized with an ACS at 6 hospitals at study sites in Central
Massachusetts and Georgia which served a heterogeneous and diverse
patient population (Waring et al., 2012; Goldberg et al., 2015). There
were 2 major teaching hospitals and 1 community hospital in Worces-
ter, MA, two Kaiser Permananete hospitals in Atlanta, GA, and a large
teaching hospital in Macon, GA. There are a total of approximately
1100 licensed beds associated with the hospitals we recruited patients
from in Central Massachusetts while the single hospital from which
we recruited patients from in Macon, Georgia, is a 630 bed tertiary
care community teaching hospital. Each of our study sites were afﬁliat-
ed with major teaching institutions including the University of Massa-
chusetts Medical School (Worcester, Massachusetts) and the Mercer
University School ofMedicine (Mercer, Georgia). The University ofMas-
sachusetts Memorial Medical Center and Worcester Medical Center all
have the capability of performing cardiac catheterization, percutaneous
coronary interventions and coronary artery bypass surgery with similar
cardiac diagnostic and interventional capabilities available at the Medi-
cal Center of Central Georgia. The city of Worcester, which is centrally
located in Massachusetts, has a population of approximately 185,000
persons, 69% of whom are white, with a median household income of
approximately $45,000 based on recent census data; 22% of residents
of this urban community are considered to be poor. The city of Macon
lies centrally in Georgia and the population is approximately 150,000;
29% of residents of thismore rural site arewhite. Based on recent census
estimates, the median household income of city residents was approxi-
mately $28,000 and 31% of the population was below the poverty line.
All eligible and consenting adult patients discharged from participating
hospitals after an ACSwere enrolled between April 2011 andMay 2013.
Since therewere so fewblack patients (n=15) recruited fromourMas-
sachusetts site, we excluded these patients from the present analysis.
We further excluded patients from our Atlanta site due to their relative-
ly small number of eligible and consenting patients.
Trained study staff abstracted extensive socio-demographic, clinical,
laboratory, physiologic, and treatment related data from themedical re-
cords of patients discharged from the hospital with an independently
validated ACS. Standard deﬁnitions of ST-segment elevation acutemyo-
cardial infarction (STEMI) and Non ST-segment elevation myocardial
infarction/unstable angina (NSTEMI/UA) were used (Waring et al.,
2012; Goldberg et al., 2015; Jneid et al., 2012).
Trained staff performed structured interviews using validated in-
struments about patients' general and condition-speciﬁc quality of life,
behavioral and lifestyle characteristics, and a variety of social factors.
We queried patients using standardized instruments about a variety of
psychosocial factors whichwould not be routinely available or collected
and recorded in hospital charts. These factors included cognitive status,
depression, anxiety, measures of perceived stress and social support,
and health literacy (Waring et al., 2012). Interviews were performed
face-to-face during the index ACS hospitalization.
Information was also collected from the review of hospital charts
about the in-hospital use of several evidence-based cardiac medica-
tions. These included the guideline recommended therapies of angio-
tensin converting enzyme inhibitors/angiotensin receptor blockers,
anticoagulants, aspirin, and beta blockers during the initial 24 h of hos-
pitalization while the use of anticoagulant agents was replaced by the
receipt of lipid lowering medications at the time of hospital discharge;
we also determined whether the patient underwent cardiac catheteri-
zation, a percutaneous coronary intervention (PCI), or coronary artery
bypass graft (CABG) surgery during their index ACS admission. Fol-
low-up of all study patients for post-discharge mortality was carried
out through the review of hospital dischargemedical records, standard-
ized telephone calls, and state and local review of death records.
3. Data analysis
Wecategorized our study sample into 3 categories:whites in Central
Massachusetts and whites and blacks in Central Georgia. Given the so-
cioeconomic gradient observed across these 3 categories, we treated
the 3-value race/place variable as an ordinal variable. Differences in se-
lected factors and study endpoints across these categories were exam-
ined using linear tests for trend and Cochran-Armitage trend tests for
continuous and categorical variables, respectively.
We assumed that it was reasonable to consider the 3 level race/place
variable as ordinal based on our conceptual understanding of the link
between socio-economic status and the health outcomes under study
in our patient population. We postulated a null hypothesis of no linear
relationship between patient-level factors and our principal study end-
points with the 3 level race/place variable at the population level. We
then used the Cochrane-Armitage trend statistic to test these null hy-
potheses of no linear association. This trend test statistic is equivalent
to the score statistics from a linear logit model testing the null hypoth-
esis of zero slope. Inasmuch, it is possible to have a signiﬁcant test result
rejecting the null hypothesis of zero slope even when the level of the
outcome variable does not increase in lock-step with the predictor var-
iable (Agresti, 2002).
Ordinal logistic regression analysis accounted for a number of poten-
tially confounding factors in examining differences in the hospital re-
ceipt of evidence-based cardiac medications, as well as 30 day and
1 year all-cause death risks, in white patients from Georgia, and black
patients from Georgia, in comparison to the referent group of white pa-
tients from Massachusetts (see table footnotes for a list of covariates).
We grouped the block of potential confounders into two blocks; ﬁrst,
we adjusted for demographic and socioeconomic factors and for comor-
bidities present at the time of hospital admission. The second block of
controlling variables included physiologic parameters and psychosocial
factors.
IRB approval was obtained from the Committee for the Protection of
Human Subjects in Research at the University of Massachusetts Medical
School and the other study sites and participating subjects provided
written informed consent.
4. Results
4.1. Study population characteristics
The studypopulation consisted of 1143whites discharged alive from
three hospitals in Central Massachusetts and 514whites and 277 blacks
discharged after an ACS from the single hospital in Central Georgia.
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Among both whites and blacks, the majority was diagnosed with an
NSTEMI/UA. The average hospital stay was 3.5 days for whites in MA
and 5.3 and 5.0 days, respectively, for whites and blacks in Georgia.
The mean age of whites from both of our study sites was 5 years
higher, these individuals were more frequently male and married, had
higher levels of education, andwere currentlyworking than blacks hos-
pitalized at theMedical Center of Central Georgia; the latter two factors
alsodiffered betweenwhites inMassachusetts andGeorgia as did differ-
ences in insurance coverage and body mass index between whites and
blacks at our respective study sites (Table 1). Whites in Georgia had
lower educational attainment, health insurance coverage, and current
employment than whites residing in Massachusetts but ranked higher
on all these factors than blacks from Georgia; for body mass index,
this ordering across the 3 race-region categories was reversed.
The 3-category ordinal gradient in terms of education, employment
status, and receipt of Medicaid beneﬁts was paralleled for many of the
comorbidities noted at the time of hospital admission. Chronic kidney
disease, coronary heart disease, prior receipt of a coronary revasculari-
zation procedure, diabetes, heart failure, hypertension, and stroke
were least prevalent among whites in Central Massachusetts and most
prevalent among blacks in Central Georgia.
In terms of physiologic factors, a three category ordinal gradientwas
not apparent, but blacks presented with higher mean blood pressures
than whites (average of 5 to 8 mmHg higher) whereas whites had
higher peak troponin ﬁndings than blacks; whites in Massachusetts
had consistently higher levels of each of these factors than whites
from Georgia (Table 1).
Whites in Massachusetts were more likely than blacks or whites in
Georgia to have chest pain/pressure as a presenting symptom (71% vs
62%). Black patients were more likely to have complained of dyspnea,
nausea/vomiting, and fatigue than whites who were more likely to
have complaints of diaphoresis and dizziness at hospital presentation
(Table 1).
There was considerable psychosocial distress manifest in our
study population and less than desirable health literacy (Table 2).
In terms of race/place differences, there appeared to be a 3-category
ordinal gradient for moderate/severe anxiety and depression,
though blacks and whites in Georgia had relatively similar ﬁndings
with regards to moderate/severe anxiety and depression, cognitive
impairment (observed in almost 50% of blacks), perceived stress
(N56% of blacks compared with approximately one third of whites
in Massachusetts and 47% of whites in Georgia), health literacy,
physical and mental health scores on the SF-36 assessment, social
support, and alcohol consumption (Table 2); while statistically sig-
niﬁcant, the mean differences in social support were relatively
small, however, and of uncertain clinical signiﬁcance
4.1.1. Hospital treatment practices
Whites from Massachusetts were more likely to have been treated
with aspirin, anticoagulants, and antiplatelet therapy during the ﬁrst
24 h of hospitalization than whites in Georgia, who were more likely
to have been treated with these medications than blacks in Georgia.
This race/place gradient was apparent for anticoagulants and antiplate-
let therapy and for the prescription of all four evidenced-based cardiac
therapies (36% of whites in Massachusetts, 18% of whites in Georgia,
and approximately 1 in every 7 blacks in Georgia) (Table 3). Differences
in these medication prescribing practices at the time of hospital dis-
charge also displayed the 3-category gradient observed previously; rel-
atively similar differences were observed in the use of pre-ACS
medications.
The gradient observed for other variables was noted for patients un-
dergoing diagnostic cardiac catheterization and for the receipt of a per-
cutaneous coronary intervention (PCI), though not for CABG surgery
(Table 3). White patients fromGeorgia were themost likely to have un-
dergone CABG surgery during their acute hospitalization, whereas
whites from Massachusetts were the least likely to have undergone
this procedure.
We examined possible race/ethnicity and/or geographic differ-
ences in the receipt of all evidence-based cardiac medications and
coronary interventional procedures while controlling for a variety
of factors that could affect the receipt of these treatment strategies
(Table 4). The results of these analyses suggested that blacks and
whites in Georgia were less likely than whites in Massachusetts to
have been sent home on all four evidence-based cardiac medications
and were less likely to have undergone a PCI. Blacks and whites in
Central Georgia were more likely to have undergone CABG surgery
Table 1
Population baseline characteristics according to race and place: TRACE-CORE.
Characteristic Central MA
Whites
(n = 1143)
Central GA
Whites
(n = 514)
Central GA
Blacks
(n = 277)
p for
trend
n % n % n %
Age (mean, yrs (std)) 1143 62.3
(11.6)
514 61.8
(10.7)
277 57.1
(10.3)
b0.001
Male 803 70.3 342 66.5 137 49.5 b0.001
Married 703 61.5 311 60.5 102 36.8 b0.001
Education
High school or less 454 39.8 273 53.1 194 70.0 b0.001
Some college 346 30.3 142 27.6 62 22.4 b0.001
College graduate 342 30.0 99 19.3 21 7.6
Currently working 541 47.3 166 32.3 78 28.2 b0.001
Insurance type
Medicaid 92 8.1 36 7.0 54 19.5 b0.001
Medicare 153 13.4 111 21.6 53 19.1 b0.01
Self-pay/no insurance 59 5.2 68 13.2 44 25.7 b0.001
Body mass index
b25 205 18.0 99 19.4 44 16.0 0.68
25–29.9 430 37.8 164 32.2 67 24.4 b0.001
≥30 503 44.2 247 48.4 164 59.6 b0.001
Medical history
ACS/MI 485 42.4 331 64.4 168 60.7 b0.001
Revascularization
procedure
358 31.3 255 49.6 112 40.4 b0.001
Atrial ﬁbrillation 96 8.4 53 10.3 16 5.8 0.50
Chronic kidney disease 108 9.5 60 11.7 48 17.3 b0.001
Chronic lung disease 200 17.5 112 21.8 48 17.3 0.46
Depression 175 15.3 52 10.1 18 6.5 b0.001
Diabetes 312 27.3 165 32.1 115 41.5 b0.001
Heart failure 108 9.5 104 20.2 68 24.6 b0.001
Hyperlipidemia 800 70.0 351 68.3 188 67.9 0.40
Hypertension 810 70.9 414 80.5 246 88.8 b0.001
Stroke 36 3.2 34 6.6 32 11.6 b0.001
Admission physiologic
factors (mean (std))
Systolic blood pressure
(mm Hg)
1132 141.3
(25.0)
512 138.5
(25.3)
277 146.5
(30.7)
b0.001
Diastolic systolic blood
pressure
(mm Hg)
1129 80.2
(25.3)
510 78.0
(17.6)
277 83.7
(19.7)
b0.05
eGFR (ml/min/1.73m2) 1129 79.9
(24.6)
487 77.4
(33.0)
270 79.3
(36.8)
0.77
Heart rate (bpm) 1132 77.3
(19.1)
510 78.4
(18.1)
276 79.6
(19.9)
0.07
Serum cholesterol
(mg/dl)
882 173.7
(46.1)
433 168.5
(55.8)
235 176.7
(52.1)
0.42
Serum glucose (mg/dl) 1080 152.1
(72.7)
496 152.4
(80.8)
275 149.4
(72.4)
0.60
Maximum troponin I
(ng/mL)
847 22.7
(36.7)
454 12.6
(27.3)
250 11.3
(27.2)
b0.001
Presenting symptoms
Chest pain/pressure 815 71.3 318 61.9 171 61.7 b0.001
Diaphoresis 263 23.0 81 15.8 55 19.9 b0.05
Dizziness 128 11.2 39 7.6 22 7.9 b0.05
Dyspnea 425 37.2 199 38.7 138 49.8 b0.001
Nausea/vomiting 216 18.9 125 24.3 78 28.2 b0.01
Palpitations 42 3.7 26 5.1 17 6.1 b0.05
Weakness/fatigue 84 7.4 62 12.1 34 12.3 b0.01
eGFR – estimated glomerular ﬁltration rate.
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during their hospitalization, but were less likely to have undergone
any coronary revascularization procedure during their acute hospi-
talization than whites in Central Massachusetts. Virtually identical
ﬁndings were observed when we controlled for the use of several
pre-ACS medications.
We also compared blacks in Georgiawithwhites in Georgia (last col-
umn of Table 4). After controlling for similar factors, blacks in Georgia
were as likely as whites in this region to have been discharged on all
four evidence-based cardiac medications. Blacks were less likely than
whites to have undergone a PCI or CABG surgery in our unadjusted anal-
yses, but these differences were attenuated after controlling for several
medical history, clinical, physiologic, and psychosocial factors. However,
receipt of any coronary revascularization approach (PCI and/or CABG
surgery) during the patient's index admission was less frequent for
blacks than whites in Georgia.
4.1.2. Thirty day and one year post discharge death risks
The 30-day and 1 year all-cause death risks were 0.4% and 2.9%, re-
spectively, among whites in Massachusetts; 1.0% and 6.1% among
whites in Georgia; and 1.4% and 6.0%, respectively, among blacks in
Georgia (Table 5).
After controlling for several previously described characteristics
of prognostic importance, whites in Georgia had an increased odds
of dying during the subsequent 30 days than whites in Massachu-
setts whereas blacks in Georgia experienced a higher odds of dying
during the ﬁrst 30 days after hospital discharge than whites in Mas-
sachusetts (Table 5); similar ﬁndings were observed when we con-
trolled for the receipt of hospital treatment practices and pre-ACS
medications.
In terms of 1 year all-cause death risks, whites and blacks in Georgia
had an increased odds of dying at this time point than whites in Massa-
chusetts, both in our unadjusted analyses and after simultaneously con-
trolling for a number of factors in our ﬁnal regression model. One year
post hospital discharge death risks were not different between whites
and blacks at our Georgia site after controlling for several factors of
prognostic importance (Table 5).
5. Discussion
The present ﬁndings illustrate a complex interplay of race and
place with regard to differences in hospital presentation, hospital
treatment practices/process measures, and 30 day and 1 year death
risks for patients discharged from the hospital after an ACS. We
observed a gradient in socio-demographic characteristics and access
Table 2
Baseline psychosocial factors according to race and place: TRACE-CORE.
Psychosocial and lifestyle factors Central MA
Whites
(n = 1143)
Central GA
Whites
(n = 514)
Central GA
Blacks
(n = 277)
p for trend
n % n % n %
Moderate/severe anxietya 226 19.8 157 30.5 78 28.2 b0.001
Moderate/severe depressionb 186 16.3 151 29.4 83 30.0 b0.001
Cognitively impairedc 122 10.7 129 25.1 136 49.1 b0.001
High perceived stressd 360 32.3 240 47.2 153 56.3 b0.001
Health literacy (good)e 777 68.3 297 58.0 142 51.5 b0.001
Low social support 63 5.5 27 5.3 22 7.9 0.22
PCS (mean(std))f 1143 44.0(10.3) 514 36.7(10.9) 277 37.5(10.3) b0.001
MCS (mean(std))f 1143 49.3(11.3) 514 45.1(14.3) 277 44.6(13.1) b0.001
Social support (mean(std)) 1128 20.6(4.5) 510 20.0(4.0) 275 18.6(4.7) b0.001
No Alcohol consumption 380 33.3 285 55.6 167 60.3 b0.001
Rare/occasional drinker 457 40.1 147 28.7 74 26.7 b0.001
Moderate/heavy alcohol consumption 304 26.6 81 15.8 36 13.0 b0.001
Current smoker 231 20.2 155 30.2 80 28.9 b0.001
Prior smoker 563 49.3 223 43.4 92 33.2 b0.001
Nonsmoker 349 30.5 136 26.5 105 37.9 0.17
MCS - mental health component summary score.
PCS - physical health component summary score.
a GAD7 general anxiety disorder 7 item score: 5–9 mild, 10–14 moderate, ≥15 severe anxiety.
b PHQ-9 patient health questionnaire 9 item score: 5–9 mild, 10–14 moderate, 15–19 moderately severe, and ≥20 severe depression.
c TICS – telephone interview for cognitive status: ≤28 impaired cognition.
d Perceived stress scale: ≥20 high perceived stress.
e Somewhat/not at all conﬁdent/little conﬁdence in ﬁlling out medical forms.
f SF-36 – mental health and physical health components.
Table 3
Hospital treatment practices according to race and place: TRACE-CORE.
Medications administered within
24 h of hospital arrival
Central MA
Whites
(n = 1143)
Central GA
Whites
(n = 514)
Central GA
Blacks
(n = 277)
p for
trend
n % n % n %
Aspirin 949 83.0 413 80.4 208 75.1 b0.01
Anticoagulants 762 66.7 246 47.9 128 46.2 b0.001
Antiplatelets 763 66.8 283 55.1 137 49.5 b0.001
Beta blockers 873 76.4 383 74.5 203 73.3 0.23
All 4 evidence-based cardiac
therapies
406 35.5 93 18.1 40 14.4 b0.001
Discharge medications
Aspirin 1121 98.1 466 90.7 234 84.5 b0.001
ACE inhibitors 623 54.5 196 38.1 120 43.3 b0.001
Beta blockers 1053 92.1 433 84.2 227 82.0 b0.001
Lipid lowering medications 1105 96.7 452 87.9 234 84.5 b0.001
All 4 evidence-based cardiac
therapies
565 49.4 141 27.4 73 26.4 b0.001
Diagnostic/interventional
procedures
Cardiac catheterization 1106 96.8 490 95.3 251 90.6 b0.001
Percutaneous coronary
intervention
836 73.1 313 60.9 144 52.0 b0.001
Coronary artery bypass surgery 117 10.2 94 18.3 41 14.8 b0.001
Percutaneous coronary
intervention or coronary artery
bypass surgery
945 82.7 397 77.2 181 65.3 b0.001
ACE – angiotensin-converting enzyme.
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to care in which Georgia whites were intermediate between the
most privileged (Massachusetts whites) and the least privileged
(Georgia blacks). This gradient was paralleled by a similar gradient
regarding the receipt of evidence-based care, with disparities
remaining even after adjustment for multiple factors. Blacks and
whites in Central Georgia fared worse than whites in Central
Table 4
Crude and multivariable adjusted odds ratios (95% conﬁdence intervals) for hospital treatment practices according to race and place: TRACE-CORE.
Central MA
Whites
(n = 1143)
Central GA
Whites
(n = 514)
Central GA
Blacks
(n = 277)
Central GA Blacks vs. Central GA Whitesc
Receipt of all evidence-based medications at hospital discharge (%) 49.4 27.4 26.4 27.1
Unadjusted odds ratios (OR's) 1.0
(Reference group)
0.39
(0.31,0.49)
0.37
(0.27,0.49)
0.95
(0.68,1.32)
Regression Model 1a 1.0 0.37
(0.29,0.47)
0.33
(0.24,0.46)
0.90
(0.63,1.27)
Regression model 2b 1.0 0.38
(0.29,0.50)
0.35
(0.24,0.50)
0.91
(0.63,1.32)
Receipt of PCI (%) 73.1 60.9 52.0 57.8
Unadjusted OR's 1.0
(Reference group)
0.57
(0.46,0.71)
0.40
(0.30,0.52)
0.70
(0.52,0.93)
Regression model 1a 1.0 0.63
(0.50,0.80)
0.47
(0.34,0.64)
0.75
(0.54,1.03)
Regression model 2b 1.0 0.68
(0.52,0.88)
0.52
(0.37,0.74)
0.77
(0.54,1.08)
Receipt of CABG surgery (%) 10.2 18.3 14.8 17.1
Unadjusted OR's 1.0
(Reference group)
1.96
(1.46,2.63)
1.52
(1.04,2.23)
0.78
(0.52,1.16)
Regression model 1a 1.0 2.19
(1.59,3.02)
1.56
(1.00,2.43)
0.71
(0.46,1.10)
Regression model 2b 1.0 1.99
(1.40,2.83)
1.50
(0.93,2.43)
0.75
(0.47,1.21)
Receipt of PCI or CABG surgery (%) 82.7 77.2 65.3 73.7
Unadjusted OR's 1.0
(reference group)
0.71
(0.55,0.92)
0.40
(0.30,0.53)
0.56
(0.40,0.77)
Regression model 1a 1.0 0.87
(0.66,1.15)
0.49
(0.35,0.70)
0.57
(0.40,0.81)
Regression Model 2b 1.0 0.91
(0.67,1.24)
0.55
(0.38,0.81)
0.61
(0.41,0.89)
CABG – coronary artery bypass grafting.
PCI – percutaneous coronary intervention.
a For each row, the ﬁrst 3 columns present the multivariable adjusted odds ratios (95% conﬁdence intervals) for an ordinal logistic regression model adjusting for age, sex, marital,
education, health insurance, and employment status, body mass index, and medical history of chronic kidney disease, coronary heart disease, depression, diabetes, heart failure, hyper-
tension, myocardial infarction, stroke, and prior coronary revascularization procedure. The last column presents the multivariable adjusted odds ratios (95% CIs) for a logistic regression
model comparing blacks vs. whites in Central Georgia, adjusting for the same covariates.
b For each row, the ﬁrst 3 columns present the adjusted odds ratios (95% conﬁdence intervals) for an ordinal logistic regressionmodel adjusting for covariates listed above plus type of
acute coronary syndrome, admission systolic and diastolic blood pressure and pulse ﬁndings, alcohol consumption, cigarette smoking, anxiety, depression, cognitive impairment, per-
ceived stress, living situation, health literacy, and SF-36 scores. The last column presents themultivariable adjusted odds ratios (95% CIs) for a logistic regression model comparing blacks
vs. whites in Central Georgia, adjusting for the same covariates.
c Reference category = Central Georgia whites.
Table 5
Crude and multivariable adjusted odds ratios (95% conﬁdence intervals) for post discharge death rates according to race and place: TRACE-CORE.
Central MA
Whites
(n = 1143)
Central GA
Whites
(n = 514)
Central GA
Blacks
(n = 277)
Central GA Blacks vs Central GA Whitesc
30 Day all-cause mortality (%) 0.4 1.0 1.4 1.10
Unadjusted OR's 1.0
(reference group)
2.80
(0.75,10.46)
4.17
(1.04,16.79)
1.49
(0.40,5.60)
Regression model 1a 1.0 3.52
(0.86,14.44)
7.83
(1.36,45.00)
2.22
(0.46,10.75)
Regression model 2b 1.0 5.71
(0.94,34.65)
8.82
(1.03,75.86)
1.55
(0.25,9.69)
1 year All-cause mortality (%) 2.9 6.1 6.0 6.1
Unadjusted OR's 1.0
(Reference group)
2.21
(1.29,3.77)
2.16
(1.14,4.10)
0.98
(0.51.1.88)
Regression model 1a 1.0 1.78
(0.97,3.26)
1.65
(0.75,3.63)
0.93
(0.44,1.96)
Regression model 2b 1.0 1.48
(0.76,2.88)
1.61
(0.67,3.85)
1.09
(0.47,2.52)
a Adjusted for age, sex,marital, education, health insurance, and employment status, bodymass index, andmedical history of chronic kidney disease, coronaryheart disease, depression,
diabetes, heart failure, hypertension, myocardial infarction, stroke and prior coronary revascularization procedure.
b Adjusted for covariates listed above plus type of acute coronary syndrome, admission systolic and diastolic blood pressure and pulse ﬁndings, alcohol consumption, cigarette smoking,
anxiety, depression, cognitive impairment, perceived stress, living situation, health literacy, and SF-36 scores.
c Reference category = Central Georgia whites.
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Massachusetts with regard to 30 day and 1 year post discharge all-
cause death risks. One needs to be careful, however, in the interpre-
tation of the present ﬁndings since we did not have a comparison
group of blacks from central Massachusetts, we lacked broader geo-
graphic representation of whites and blacks from other regions of
the U.S., and our event rates were relatively low.
5.1. Patient characteristics
Black patients discharged from the hospital after an ACS in Georgia
were relatively young, a lower proportion attended college, and a higher
proportion had been previously diagnosed with several important co-
morbidities as compared with white patients at our Georgia andMassa-
chusetts sites.
Similar differences in these characteristics between black and
white patients were observed in the CRUSADE study (Mathews et
al., 2014). The N3000 black patients with an NSTEMI included in
this investigation were several years younger than whites, and had
a higher prevalence of previously diagnosed cardiovascular disease
related comorbidities (Mathews et al., 2014). Similar ﬁndings were
reported among those included in ﬁve large randomized clinical tri-
als of patients with acute coronary disease carried out between 1990
and 2001 (Mehta et al., 2006).
While the reasons for these differences are unknown, it was of inter-
est to note the higher blood pressure ﬁndings and peak troponin levels
among whites hospitalized with an ACS in Central Massachusetts as
compared with whites in Central Georgia. This could have been due to
differences in patient's care seeking behavior, number, timing, and ac-
curacy of these measurements, or to the severity of the acute coronary
episode.
In comparing our results to these and other investigations, it is im-
portant to note that the other cited studies are somewhat dated and
one study included a narrowly deﬁned patient population. The TRACE-
CORE investigation is a contemporary prospective cohort study that in-
cluded patients across the spectrum of an ACS, with a wide range of so-
cioeconomic diversity.
5.2. Psychosocial and behavioral characteristics
There was considerable psychosocial distress and vulnerability re-
ported by our study population. A considerable proportion of patients
had anxiety and depression and poor health literacy and a wide range
of cognitive impairment was observed. It needs to be noted, however,
that in many of the study patients, their psychological distress may
have been transient and a reaction to their acute illness and hospitaliza-
tionwhile in others, their anxiety and depressionmay persist after hos-
pital discharge; it is unknown how these psychosocial patterns may
have differed according to race and study location.
Black patients were more likely to have moderate/severe symptoms
of depression, be cognitively impaired, have higher levels of perceived
stress, have poorer health literacy, be current smokers, and reported
consuming either none or more moderate amounts of alcohol as com-
paredwithwhite patients. On the other hand,white patients discharged
from thehospital after anACS reported a higher quality of life but higher
prevalence of lifetime depression than blacks.
Few clinical/epidemiologic studies have examined differences in
various psychosocial factors or lifestyle characteristics between white
and black patients hospitalized with an ACS (Spertus et al., 2009;
Mathews et al., 2014; Mehta et al., 2006). In the PREMIER study of
N1800 patients hospitalized with an acute myocardial infarction
(AMI) in 10 hospitals in California andMissouri, black patients present-
ed with a worse psychosocial proﬁle and poorer quality of life than
white patients (Spertus et al., 2009). Similarly, in the TRIUMPH study,
patients with higher scores on the perceived stress scale were more
likely to be non-white (Agresti, 2002).
With regard to lifestyle factors, we found that a lower proportion of
patients from Georgia reported consuming alcohol but a higher propor-
tion were current smokers as compared with whites in Massachusetts.
Investigators in the CRUSADE, GUSTO/ASSENT, and PREMIER studies
found a higher proportion of current smokers in black than in white pa-
tients (Spertus et al., 2009; Mathews et al., 2014; Mehta et al., 2006).
Given the high frequency and associated burden of psychosocial vul-
nerability demonstrated in our relatively young study population,
health care providers should consider screening for these important
lifestyle and psychosocial factors in all patients who develop an ACS.
These factors have been associated with failure to understand post-dis-
chargemedication and lifestyle change instructions, the progressive na-
ture of the patient's underlying disease process, long-term adherence to
effective cardiac medications, and worse long-term outcomes.
5.3. Hospital treatment practices
We observed a relatively lower utilization of effective cardiac medi-
cations in patients from Georgia during the initial 24 h of their hospital-
ization for an ACS and at the time of hospital discharge with no
differences noted between blacks and whites at our Georgia site. A
lower proportion of patients fromGeorgia underwent some formof cor-
onary revascularization than whites fromMassachusetts with black pa-
tients from Georgia being less likely to have undergone either a PCI or
CABG surgery during their index hospitalization than whites from this
region.While the reasons for these differences are unknown, the hospi-
tal length of stay was considerably longer for patients hospitalized with
an ACS in Central Georgia as compared with Central Massachusetts, on
average nearly 2 days longer. Thismay reﬂect differences in the severity
of disease, hospital discharge policies and timing of admission and/or
discharge, or in other factors between the 2 study sites.
In the CRUSADE study, black patients were less likely to have been
prescribed evidence-based cardiac medications than whites and to
have undergone cardiac catheterization and a PCI during their hospital-
ization (Sonel et al., 2005). Black patients in the PREMIER study were
signiﬁcantly less likely to have undergone cardiac catheterization, PCI,
and CABG surgery than whites and were also less likely to have been
treated with evidence-based medications at hospital discharge
(Spertus et al., 2009).
Geographic differences have been observed with regards to the re-
ceipt of various cardiac medications and coronary interventional proce-
dures among patients with cardiovascular and cerebrovascular disease
in the U.S. (Gebreab and Diez Roux, 2012; Arnold et al., 2012; Glasser
et al., 2008; Yong et al., 2014) In the REGARDS study of middle-aged
and older adults living in the U.S. stroke belt (Glasser et al., 2008), one
third of study participants reported prophylactic aspirin use, with this
usage being signiﬁcantly more common among whites than blacks.
These and other ﬁndings that have been observed with regards to
race and place in terms of the descriptive epidemiology of CHD need
to be cautiously interpreted, however, given the effects of assessing
one acute illness episode in a complex disease process. Racial as well
as geographic disparities in the management and outcomes of patients
hospitalized with an ACS may be due to patient's health insurance cov-
erage and extent of ﬁnancial resources, socio-cultural and racial biases
and response to theunderlying and acute disease state, acute presenting
symptoms, extent of delay in seeking acute medical care, residual con-
founding by other factors, differences in the severity of acute coronary
disease, or to the reluctance of certain patient subgroups to undergo car-
diac interventional procedures or be medically treated in an aggressive
manner (Graham, 2014).
5.4. Post discharge mortality risks
Researchers in the ARIC study, GUSTO, ASSENT, and PREMIER failed
to ﬁnd signiﬁcant differences in the in-hospital, 30-day, or 1-year mor-
tality rates between whites and blacks after adjusting for several
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potential confounding variables of prognostic importance (Spertus et
al., 2009; Ding et al., 2003). In the CRUSADE study, blacks had lower
30-day multivariable adjusted death rates but similar 1-year death
rates (Sonel et al., 2005).
Both black and white patients from our site in Georgia were at
higher risk for dying at 30 days and 1 year post hospital discharge
than patients hospitalized for an ACS in Massachusetts. While there
were no differences noted between blacks and whites at our Georgia
site with regard to post hospital discharge death rates, blacks in Georgia
were at greater odds for dying at 30 days after hospital discharge than
whites in Massachusetts.
The present ﬁndings need to be cautiously interpreted, however,
since a myriad of post discharge factors that may inﬂuence patient's
downstream outcomes need to be considered in the interpretation of
race and/or geographic differences in post discharge death risks after
hospital discharge for an ACS. Moreover, the 30 day and 1 year risks
of dying observed in the present study were relatively low and, as
such, any between group/site differences need to be cautiously
interpreted.
Factors to consider in explaining any possible race/place differences
in the prognosis of patients after an ACS include the trajectory of the
patient's underlying condition prior to the index event, adherence to
cardiac medications prescribed and receipt of subsequent cardiac inter-
ventional procedures, physician follow-up after hospital discharge, so-
cial and ﬁnancial support, and changes in psychosocial and lifestyle
factors over time.
5.5. Study strengths and limitations
The strengths of the present prospective study include the large and
diverse sample of patients hospitalized with an ACS and use of stan-
dardized data collection instruments to ascertain various measures of
psychosocial and lifestyle characteristics. As mentioned previously,
however, our ﬁndings need to be carefully interpretedwith appropriate
reservation. The role of multimorbidity in these patients and studying a
single clinical event in a complex condition and its natural history need
to be considered in the evaluation of our study results. Unfortunately,
the demographic characteristics of residents of Central Massachusetts
are such that we could not conduct meaningful analyses on racial dis-
parities within Massachusetts. We also cannot exclude the possible
roles of information bias in eliciting possible differential responses to
our baseline, in-hospital, study questionnaires according to race and
place, possible selection bias in the characteristics of participating
study subjects, and the role of other potentially confounding factors
that we either did not collect information on, or were inadequately
measured, such as health insurance or socioeconomic status, family
support and situational factors, and extent of knowledge about ACS
and its treatment.
6. Conclusions
The results of this contemporary cohort study provide insights
into the presenting symptoms, socio-demographic, psychosocial,
and clinical characteristics, hospital medical practices, and risk of
dying in white and black patients discharged from the hospital
after an ACS. Whites in Georgia were more socially disadvantaged
and underwent less evidence-based care than whites in Massachu-
setts, and blacks in Georgia were even worse off than whites in Geor-
gia, thus perhaps placing them in “double jeopardy”. These ﬁndings
reinforce the need for more broadly based contemporary data and
for additional research to try to understand what may be causal ex-
planations including system and physician level variables as well as
ﬁnancial factors.
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